Medication info
Wonpolmin Tablet (Metformin Hydrochloride)

Wonpolmin Tablet (Metformin Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Metformin Hydrochloride›500mg / 1 tablet
Manufacturer / importer
Daewon Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablet
Packaging
300 tablets/bottle
Approval status
Active

MFDS item code 200401756 · Notified 2004.02.06 · Insurance code 671802680

Summary

Main use
Treatment of type 2 diabetes mellitus
Who takes it
Adults · Children
Adult dose
The dose should be determined individually based on efficacy and tolerability and should not exceed the recommended maximum daily dose. This medicine must be started at a low dose to reduce gastrointestinal adverse reactions and to identify the minimum dose required for adequate blood glucose control. Administer 500mg per dose, 2~3 times daily, with meals. Increase the dose gradually by 500mg each week. When doses up to 2000mg are used, the dose is usually divided into 2 doses daily, in the morning and evening. For doses exceeding 2000mg, administer in 3 divided doses with meals; the maximum daily dose is 2550mg. At treatment initiation and during dose adjustment, fasting blood glucose should be measured to evaluate the response to treatment with this medicine and identify the minimum effective dose. Glycated hemoglobin concentration should be measured at approximately 3-month intervals. The goal of treatment with this medicine, whether administered as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and glycated hemoglobin concentrations to normal or near-normal levels using the minimum effective dose. In general, if blood glucose is temporarily uncontrolled in a patient whose blood glucose had been controlled by diet alone, short-term administration of this medicine may be sufficient to achieve an adequate effect. This medicine may be used in patients with moderate stage 3a renal impairment (creatinine clearance [CrCl] 45≤~<60ml/min or glomerular filtration rate (GFR) 45≤~<60mL/min/1.73㎡) who do not have other symptoms that may increase the risk of lactic acidosis, using the following dose adjustment: - The starting dose is 500mg or 850mg once daily. The maximum daily dose is 1000mg, administered in 2 divided doses. Renal function should be monitored closely every 3-6 months. If creatinine clearance or glomerular filtration rate decreases to below 45ml/min or 45ml/min/1.73㎡, respectively, administration of this medicine must be discontinued immediately.
Child dose
Children aged 10 years and older or adolescents during growth: The usual starting dose is 500 milligrams once daily, administered during or after a meal. Blood glucose levels should be measured after one week and the dose adjusted accordingly. Gastrointestinal adverse effects may improve with gradual dose increases. The maximum daily dose is 2000mg. This dose should be divided into 2~3 administrations.

Ingredients

Manufacturer
Daewon Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of type 2 diabetes mellitus

  • Type 2 diabetes
  • poor blood sugar control
  • overweight
View approved original text

This medication is used for the treatment of patients with Type 2 diabetes whose blood sugar control is insufficient with diet and exercise alone. It is particularly effective in overweight adult patients and can be used alone or in combination with other oral hypoglycemic agents or insulin in adults. Additionally, it helps to control blood sugar levels in children over the age of 10 and adolescents during growth, either as monotherapy or in combination with insulin. This medication plays a crucial role in diabetes management by stabilizing blood sugar levels and contributes to improving the patient's health.

How to take

Adult dose

The dose should be determined individually based on efficacy and tolerability and should not exceed the recommended maximum daily dose. This medicine must be started at a low dose to reduce gastrointestinal adverse reactions and to identify the minimum dose required for adequate blood glucose control. Administer 500mg per dose, 2~3 times daily, with meals. Increase the dose gradually by 500mg each week. When doses up to 2000mg are used, the dose is usually divided into 2 doses daily, in the morning and evening. For doses exceeding 2000mg, administer in 3 divided doses with meals; the maximum daily dose is 2550mg. At treatment initiation and during dose adjustment, fasting blood glucose should be measured to evaluate the response to treatment with this medicine and identify the minimum effective dose. Glycated hemoglobin concentration should be measured at approximately 3-month intervals. The goal of treatment with this medicine, whether administered as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and glycated hemoglobin concentrations to normal or near-normal levels using the minimum effective dose. In general, if blood glucose is temporarily uncontrolled in a patient whose blood glucose had been controlled by diet alone, short-term administration of this medicine may be sufficient to achieve an adequate effect. This medicine may be used in patients with moderate stage 3a renal impairment (creatinine clearance [CrCl] 45≤~<60ml/min or glomerular filtration rate (GFR) 45≤~<60mL/min/1.73㎡) who do not have other symptoms that may increase the risk of lactic acidosis, using the following dose adjustment: - The starting dose is 500mg or 850mg once daily. The maximum daily dose is 1000mg, administered in 2 divided doses. Renal function should be monitored closely every 3-6 months. If creatinine clearance or glomerular filtration rate decreases to below 45ml/min or 45ml/min/1.73㎡, respectively, administration of this medicine must be discontinued immediately.

Child dose

Children aged 10 years and older or adolescents during growth: The usual starting dose is 500 milligrams once daily, administered during or after a meal. Blood glucose levels should be measured after one week and the dose adjusted accordingly. Gastrointestinal adverse effects may improve with gradual dose increases. The maximum daily dose is 2000mg. This dose should be divided into 2~3 administrations.

Precautions

This medication can cause lactic acidosis, a dangerous condition that results from excessive accumulation of lactic acid in the body, and should not be used in patients with severe renal impairment, acute heart disease, infections, or dehydration. Additionally, this medication should be temporarily discontinued before acute heart failure or certain radiologic examinations, and patients who have had allergic reactions to this medication or similar drugs should not take it. The use of this medication should be carefully considered in pregnant patients or those with severe liver dysfunction, and in patients with severe infections or trauma that negatively impact their health. Patients should be cautious of low blood sugar risks during treatment if they skip meals, excessively exercise, or take this medication with other drugs. Common side effects include gastrointestinal symptoms such as diarrhea, nausea, and vomiting, which typically appear in the early stages of treatment and resolve naturally over time. Rarely, side effects such as decreased vitamin B12 levels in the blood, liver dysfunction, skin rashes, and hypoglycemia may occur, so regular testing is necessary. Renal function should be monitored regularly during treatment, and if renal function declines, the use of this medication should be discontinued. Moreover, the risk of lactic acidosis may increase if this medication is taken with alcohol, so it is advisable to avoid drinking. The effects of this medication on the fetus during pregnancy are not fully understood, so it should only be used after consulting with a doctor if pregnancy is planned or occurs. As this medication is secreted into breast milk, careful consideration should be given to whether to continue breastfeeding or discontinue medication. Elderly patients may experience decreased renal function, so dosage adjustments and regular monitoring of renal function are necessary. In cases of overdose, the medication can be removed through hemodialysis, so patients should seek immediate medical attention. Finally, this medication may interact with other hypoglycemic agents, so patients must inform their doctor or pharmacist about any other medications they are taking.

Side effects

  • Lactic acidosis
  • diarrhea
  • nausea
  • vomiting
  • abdominal distension
  • loss of appetite
  • indigestion
  • constipation
  • abdominal pain
  • metallic taste
Show 7 more
  • rash
  • anemia
  • leukopenia
  • thrombocytopenia
  • vitamin B12 deficiency
  • liver function abnormalities
  • hypoglycemia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. It is advisable to maintain storage temperatures between 1°C and 30°C at room temperature. This helps to preserve the drug's effectiveness and safety for an extended period.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.